Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds. The reason for such a low rate, researchers suggest, may be a lack of time for providing the counseling or expertise in this area by clinicians.
Há muitos anos, pessoas têm utilizado o jejum intermitente para perder quilos indesejados, enquanto outras jejuam por razões religiosas. A tendência popular da dieta é geralmente segura, mas alguns estudos sugerem que comer com restrição de tempo pode causar problemas cardíacos.
Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Women experiencing moderate-to-severe vasomotor symptoms face a three times greater risk for metabolic-dysfunction-associated steatotic liver disease (MASLD) compared to those with mild symptom severity, according to research being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
People under age 50 have a greater risk for heart attack or stroke if they’ve lived with obesity for 10 years, according to industry-sponsored research being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
The cardiovascular ICU at the University of Mississippi Medical Center developed a simulation training program to improve clinicians’ ability to recognize clinical signs that would prompt an emergency ICU sternotomy for a postoperative cardiac surgery patient and rehearse the high-risk but infrequent procedure.
A new study presents the development of 3D printed electrospun vascular grafts infused with tetramethylpyrazine (TMP), offering a potential solution to reduce thrombosis and restrain aneurysmal dilatation post-surgery. This innovation has potential implications for improving cardiovascular disease treatments.
A new mouse study of heart failure with preserved ejection fraction (HFpEF) found sex differences at the cellular level. The findings could have implications for how HFpEF is treated in women compared to men.
The Ludmila and Edward Smolyansky Foundation, the philanthropic arm Pure Culture Organics of Chicago, IL, announced today it has made a $1 million commitment to Ann & Robert H. Lurie Children’s Hospital of Chicago, specifically allocated to the Cardiology Program Fund and the Access for Every Child Fund.
A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.
In 2023, the U.S. Food and Drug Administration in 2023 approved the world’s first leadless dual-chamber pacemaker, a potential gamechanger for the nearly 80% of patients who require pacing of both the upper and lower chambers of the heart. UT Southwestern is one of just nine heart centers in Texas to offer this advanced technology, which implants two capsule-shaped devices smaller than AAA batteries directly inside the heart in a catheter-based procedure, with no large incisions and no lead wires.
La mayoría de la gente ha oído hablar de ataques cardíacos que se producen debido al bloqueo de una arteria coronaria. Sin embargo, el cuerpo tiene dos tipos de sistemas arteriales: el sistema de la arteria coronaria, conectado al corazón, y el sistema arterial periférico, que involucra las arterias que transportan sangre oxigenada a los brazos, piernas, cerebro y el resto del cuerpo.
Not for public release
This news release is embargoed until 27-May-2024 5:00 PM EDT
Released to reporters: 21-May-2024 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 27-May-2024 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.
Not for public release
This news release is embargoed until 19-May-2024 5:15 PM EDT
Released to reporters: 13-May-2024 8:05 AM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 19-May-2024 5:15 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Mice experiencing “social jet lag” developed characteristics similar to people with the same phenomenon, including significant weight gain, higher blood sugar levels and lower cardiovascular fitness.
A recent publication in the American Heart Association Circulation highlights the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia.
MedStar Washington Hospital Center is the first in the greater Washington and Baltimore regions to use the FARAPULSE™ Pulsed Field Ablation (PFA) System, an innovative cardiac ablation therapy to treat atrial fibrillation (AFib), the most common heart rhythm disorder in adults. Traditional ablation therapies have relied on heat or cold energy to block the abnormal electrical signals responsible for AFib.
Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.
A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.
Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.
Hackensack Meridian Hackensack University Medical Center and Hackensack Meridian Jersey Shore University Medical Center cardiologists have treated their first patients this week with the Medtronic PulseSelect Pulsed Field Ablation (PFA) System.
Not for public release
This news release is embargoed until 13-May-2024 4:00 PM EDT
Released to reporters: 7-May-2024 1:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 13-May-2024 4:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Understanding the human exposome — a person’s myriad health exposures over a lifetime — can reveal unknowns about diseases not explained fully by our DNA. Artificial intelligence will be indispensable in efforts to understand the role of biology and environment in disease and health.
One of the most common genetic heart diseases worldwide, hypertrophic cardiomyopathy (HCM) causes the walls of the left ventricle to become thick and stiff. In about 70 percent of cases, patients with HCM experience obstruction to blood flow, which increases pressures in the heart and can lead to chest pain, shortness of breath and reduced exercise capacity.
There are currently no medical treatments for thoracic aortic aneurysm. Using human cells in laboratory rats, researchers have developed a functional model of thoracic aortic aneurysm, creating opportunities for more effective understanding of disease development and treatments for the potentially fatal condition, a study suggests.
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.
Children’s Hospital Los Angeles recently conducted a 30-year study of more than 300 pediatric patients who underwent the Ross procedure at CHLA to determine how a patient’s age and heart anatomy impact the surgery’s success.
An artificial intelligence (AI) program developed by investigators in the Smidt Heart Institute and their Cedars-Sinai colleagues can detect a type of abnormal heart rhythm that can go unnoticed during medical appointments, according to a new study.
The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Jeffrey W. Moses, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30, 2024, in Washington, DC, at the Walter E. Washington Convention Center.
Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease.
Artificial intelligence experts at Cedars-Sinai and the Smidt Heart Institute created a dataset with more than 1 million echocardiograms, or cardiac ultrasound videos, and their corresponding clinical interpretations. Using this database, they created EchoCLIP, a powerful machine learning algorithm that can “interpret” echocardiogram images and assess key findings.
Running, cycling, or swimming – if you regularly exercise, you’re well on track for a long and healthy life, as groundbreaking new research from the University of South Australia finds that an increased cardio fitness level will reduce your risk of death from any cause by 11-17%.
NASSAU, Bahamas, April 26, 2024 /PRNewswire/ -- Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its cutting-edge JuxtaFlow® Renal Assist Device (RAD). This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study, coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting. It marks a significant leap forward in safeguarding kidney function for patients undergoing cardiac surgeries, addressing a key challenge in cardiothoracic surgery and critical care.
The expanding use of transcatheter technologies has changed the landscape in the treatment of valvular disease in adult cardiac patients, with valve surgery rapidly shifting to more complex interventions frequently involving other concomitant procedures.
A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.
The American Heart Association has named MedStar Washington Hospital Center Cardiologist Reginald Robinson, MD, its 2024 Physician of the Year. Dr. Robinson has more than two decades of service and leadership with AHA and has worked in the field of cardiology to improve the care of patients and the community.
Surgeons from the Smidt Heart Institute at Cedars-Sinai will be attending the American Association for Thoracic Surgery (AATS) Annual Meeting April 27-30 in Toronto and are available to discuss the latest cardiac surgery news and research.
Ageless and evergreen: The signature lyric that sums up Robin Lipman’s reverence for one of the most iconic entertainers of our time. That epic level of fan appreciation would manifest in a fundraising campaign to benefit the Barbra Streisand Women’s Heart Center at the Smidt Heart Institute at Cedars-Sinai.
When one study says a treatment works, but another says it doesn’t (or worse), how are clinicians supposed to determine what they should do? A Penn Medicine team recently received funding from PCORI to build a guide system for these situations